Broadcast

e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Broadcast

e-SPACE CRM 2025 – Day One

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Watch time: 5m 46s

Broadcast

Medical Options for Advanced HFpEF/HFmrEF Patients

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s

Broadcast

Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al

Watch time: 1h 34m 52s

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Articles

Finerenone: Will It Be a Game-changer?

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

Aldosterone and Potassium in Heart Failure

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

Mineralocorticoid Receptor Antagonists in Heart Failure

Published:

12 November 2024

Citation:

Cardiac Failure Review 2024;10:e15.

GLP-1RA in Different HFpEF Phenotypes

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.